MassDevice Earnings Roundup
Diabetes: DexCom shatters Q3 expectations, shares surge to 52-week high
Dexcom Inc. (NSDQ:DXCM) shares are surging today after the medical device company reported 3rd-quarter sales and earnings results that shattered expectations and affirmed its outlook for the rest of the year.
HeartWare soars on Q3 sales, earnings beat
HeartWare International (NSDQ:HTWR) shares gained 15% this morning after the medical device company crushed forecasts with its 3rd-quarter sales and earnings figures, reporting stronger-than-expected sales of its left ventricular assist device implantable heart pump.
BD announces management changes as Q4 profits slide on legal settlement
Becton Dickinson & Co. (NYSE:BDX) beat Wall Street’s estimates for its 4th quarter of 2013 and handed out a couple of promotions during the company’s quarterly conference call with investors.
Endo Health announces a lifesciences mega-buy and Street-beating Q3
There are big things afoot at Endo Health Solutions (NSDQ:ENDP), which announced plans to pick up specialty pharmaceuticals maker Paladin Labs in a deal valued at $1.6 billion.
Hospira beats The Street with 3rd-quarter earnings
Mako management discuss Q2 earnings
Abiomed management discuss Q2 2014 results
Abiomed flirts with 52-week high on Q2 results
Endologix posts Q3 sales surge but losses widen
Endologix (NSDQ:ELGX) posted sales growth of nearly 25% during the 3rd quarter, but losses widened by nearly 58%.
Irvine, Calif.-based Endologix posted losses of $9.5 million, or 14¢ per share, on sales of $33.3 million for the 3 months ended Sept. 30. That’s a profit slide of 57.9% on sales growth of 24.6% compared with the same period last year.
Staar Surgical swings to Q3 black
Staar Surgical (NSDQ:STAA) put black ink into its ledger for the 3rd quarter, beating Wall Street’s earnigns expectations in the process.